ReviewCancers2024
Social and Biological Determinants in Lung Cancer Disparity.
Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 25 citations in OpenAlex.
- Personalized environmental risk communication and cancer screening intent among rural private well users.Preventive medicine reports · 2026Article
- The relationship between activities of daily living, frailty, and care dependency in older adults with lung cancer.Cancer causes & control : CCC · 2026Article
- Disparities in initiating standard first-line cancer treatment and survival for patients with an immigrant background: a Danish register-based cohort study.Acta oncologica (Stockholm, Sweden) · 2026Observational
- Article
- Variation in LINE-1 ORF1p expression across histologic and demographic subgroups in non-small cell lung cancers.Translational oncology · 2026Article
- Association of medicaid expansion with lung cancer-specific and overall mortality: A difference-in-differences analysis.PloS one · 2026Article
- Negative social determinants of health are linked to lung cancer screening underutilization.Lung cancer management · 2025Article
- Educational and Equity Implications of Biomarker Testing and Targeted Therapy Access in NSCLC: Insights from the NIH All of Us Research Program.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025Article
- Age-Based Screening for Lung Cancer Surveillance in the US.JAMA network open · 2025Article
- Survival Determinants and Sociodemographic Disparities in Early-Onset Non-Small Cell Lung Cancer.JAMA network open · 2025Article
- Impact of Medicaid Expansion on Lung Cancer Survival Outcomes: A Difference-in-Differences Analysis.medRxiv : the preprint server for health sciences · 2025Article
- A Systematic Review of AI Performance in Lung Cancer Detection on CT Thorax.Healthcare (Basel, Switzerland) · 2025Review
- Review
- Temporal trends in the burden of tracheal, bronchial, and lung cancer in China and globally: A comprehensive analysis from 1990 to 2021.Chinese medical journal pulmonary and critical care medicine · 2025Article
- Translating premalignant biology to accelerate non-small-cell lung cancer interception.Nature reviews. Cancer · 2025Review
- Equity and Opportunities in Lung Cancer Care-Addressing Disparities, Challenges, and Pathways Forward.Cancers · 2025Review
- Social determinants of health in lung cancer surgery: perspectives from family caregivers, clinicians, and healthcare system administrators.Frontiers in public health · 2025Article
- Gender disparities in lung cancer and social determinants of environmental risk: a geospatial analysis across Illinois counties.Frontiers in public health · 2025Article
- Identifying priority populations for lung cancer screening intervention using neighborhood-level factors and cancer registry data.Preventive oncology & epidemiology · 2024Article
- Trend Analysis of Lung Cancer Incidence and Mortality in Xiamen (2011-2020).Risk management and healthcare policy · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
Lung cancer remains a leading cause of death in the United States and globally, despite progress in treatment and screening efforts. While mortality rates have decreased in recent years, long-term survival of patients with lung cancer continues to be a challenge. Notably, African American (AA) men experience significant disparities in lung cancer compared to European Americans (EA) in terms of incidence, treatment, and survival. Previous studies have explored factors such as smoking patterns and complex social determinants, including socioeconomic status, personal beliefs, and systemic racism, indicating their role in these disparities. In addition to social factors, emerging evidence points to variations in tumor biology, immunity, and comorbid conditions contributing to racial disparities in this disease. This review emphasizes differences in smoking patterns, screening, and early detection and the intricate interplay of social, biological, and environmental conditions that make African Americans more susceptible to developing lung cancer and experiencing poorer outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.